Isoflavone Genistein: Photoprotection and Clinical Implications in Dermatology

Journal of Nutrition

Volumn 133, Issue 11 SUPPL. 1, 2003, Pages

  Wei, Huachen ^a   Saladi, Rao ^a   Lu, Yuhun ^a   Wang, Yan ^a   Palep, Sapna R ^a   Moore, Julian ^a   Phelps, Robert ^a   Shyong, Eileen ^a   Lebwohl, Mark G ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoprevention; Dermatology; Genistein; Photoaging; Photocarcinogenesis

Indexed keywords

CASPASE 3; CYCLINE; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); GENISTEIN; ISOFLAVONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN TYROSINE KINASE; PSORALEN;

AGING; ANTIOXIDANT ACTIVITY; BREAST CANCER; CANCER INHIBITION; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CUTANEOUS PARAMETERS; DERMATOLOGY; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; DRUG ACTIVITY; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; MELANOMA; MENOPAUSAL SYNDROME; NONHUMAN; OSTEOPOROSIS; PROSTATE CANCER; PUVA; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; SKIN DEFECT; SKIN PROTECTION; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION;

ANIMALIA; GLYCINE MAX;

EID: 0242610803     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.11.3811s     Document Type: Conference Paper

References (59)

1. Armstrong, B. & Doll, R. (1975) Environmental factors and cancer incidence and mortality in different countries, with specific reference to dietary practices. Int. J. Cancer 15: 617-631.
2. Correa, P. (1981) Epidemiological correlations between diet and cancer frequency. Cancer Res. 41: 3685-3690.
3. Doll, R. & Peto, R. (1992) The cause of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66: 1191-1308.
4. Tham, D. M. (1998) Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83: 2223-2235.
5. Messina, M. & Barnes, S. (1991) The role of soy products in reducing risk of cancer. J. Natl. Cancer Inst. 83: 541-546.
6. Messina, M., Persky, V., Setchell, K. & Barnes, S. (1994) Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 21: 113-131.
7. Wet, L. G., Birac, P. M. & Pratt, D. E. (1978) Separation of the isomeric isoflavones from soybeans by high-performance liquid chromatograph. J. Chromatogr. 150: 266-268.
8. Cheng, E., Story, C. D., Yoder, L., Hale, W. H. & Burrough, W. (1953) Estrogenic activity of isoflavone derivatives extracted and prepared from soybean oil meal. Science 118: 164-165.
9. Batterham, T. J., Hart, N. K. & Lamberton, J. A. (1965) Metabolism of oestrogenic isoflavones in sheep. Nature 4983: 509.
10. Murray, P. A., Farmakalidis, E. & Johnson, L. D. (1982) Isoflavone content of soya-based laboratory animal diets. Food Chem. Toxicol. 20: 315-317.
11. Livinston, A. L. (1978) Forage plant estrogens. J. Toxicol. Environ. Health 4: 301-324.
12. Shemesh, M., Lindner, H. R. & Ayalaoan, N. (1972) Affinity of rabbit uterine oestradiol receptor for phyto-oestrogens and its use in a competitive protein-binding radioassay for plasma coumestrol. J. Reprod. Fertil. 29: 1-9.
13. Gyorgy, P., Murata, K. & Ikehata, H. (1964) Antioxidants isolated from fermented soybeans (tempeh). Nature 203: 870-872.
14. Pratt, D. E., Di Pietro, C., Porter, W. L. & Giffee, J. W. (1981) Phenolic antioxidants of soy protein hydrolyzates. J. Food Sci. 47: 24-25.
15. Jha, H. C., von Recklinghausen, G. & Zilliken, F. (1985) Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochem. Pharmacol. 34: 1367-1369.
16. Lundh, T. J. O. & Lundgren, B. O. (1991) Uncoupling and inhibition of the respiratory chain in rat liver mitochondria by some naturally occurring estrogens and their metabolites. J. Agric. Food Chem. 39: 736-739.
17. Bartholomew, R. M. & Ryan, D. S. (1980) Lack of mutagenicity of some phytoestrogens in the salmonella/mammalian microsome assay. Mutat. Res. 78: 317-321.
18. Nagao, M., Morita, N., Yahagi, T., Shimizu, M., Kuroyanagi, M., Fukuoka, M., Yoshihira, K., Natod, S., Fujino, T. & Sugimura, T. (1981) Mutagenicities of 61 flavonoids and 11 related compounds. Environ. Mutagen. 3: 401-419.
19. Huang, M.-T., Wood, A. W., Newmark, H. I., Sayer, J. M., Yagi, H., Jerina, D. M. & Conney, A. (1983) Inhibition of the mutagenicity of bay-region diolepoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids. Carcinogenesis 4: 1631-1637.
20. Chae, Y. H., Marcus, C. B., Ho, D. K., Cassady, J. M. & Baird, W. M. (1991) Effects of synthetic and naturally occurring flavonoids on benzo[a] pyrene metabolism by hepatic microsomes prepared from rats treated with cytochrome P-450 inducers. Cancer Lett. 60: 15-24.
21. Albertazzi, P., Pansini, F., Bottazzi, M., Bonaccorsi, G., De Aloysio, D. & Morton, M. S. (1999) Dietary soy supplementation and phytoestrogen levels. Obstet. Gynecol. 94: 229-231.
22. Albertazzi, P., Steel, S. A., Clifford, E. & Bottazzi, M. (2002) Attitudes towards and use of dietary supplementation in a sample of postmenopausal women. Climacteric. 5: 374-382.
23. Yamaguchi, M. & Goa, Y. H. (1998) Genistein inhibits bone loss. Biochem. Pharmacol. 55: 71-76.
24. Weggeman, R. M. & Trautwein, E. A. (2003) Relation between soy-associated isoflavones and LDL/HDL cholesterol concentrations in humans: a meta-analysis. Eur. J. Clin. Nutr. 57: 940-946.
25. Kapiotis, S., Hermann, M., Held, I., Seelos, C., Ehringer, H. & Gmeiner, B. M. (1997) Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by athrogenic LDL. Arterioscler. Thromb. Vasc. Biol. 17: 2868-2874.
26. Nestel, P. J., Yamashita, T., Sasahara, T., Pomeroy, S., Dart, A., Komesaroff, P., Owen, A. & Abbey, M. (1997) Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler. Thromb. Vasc. Biol. 17: 3992-3998.
27. Wilcox, J. N. & Blumenthal, B. F. (1995) Thrombotic mechanism in atherosclerosis: potential impacts of soy proteins. J. Nutr. 125: 624S-630S.
28. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M. & Fukami, Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262: 5592-5595.
29. Yamashita, Y., Kawada, S. & Nakano, H. (1990) Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem. Pharmacol. 39: 737-744.
30. Linassier, C., Pierre, M., Le Peco, J.-B. & Pierre, J. (1990) Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem. Pharmacol. 39: 187-193.
31. Ernould, A.-P., Ferry, G., Genton, A., Cudennec, C. A. & Boutin, J. A. (1990) Use of the main tyrosine protein kinase activity purified from HL-60 in the search for a new class of anticancer compounds. Anticancer Res. 10: 197-202.
32. Okura, A., Arakawa, H., Oka, H., Yoshinari, T. & Monden, Y. (1988) Effect of genistein on topoisomerase activity and on the growth of [VAL 12] Ha-ras-transformed NIH 3T3 cells. Biochem. Biophys. Res. Commun. 157: 183-189.
33. Zwiller, J., Sassone-Corsi, P., Kakazu, K. & Boyton, A. L. (1991) Inhibition of PDGF-induced c-jun and c-fos expression by a tyrosine protein kinase inhibitor. Oncogene 6: 219-221.
34. Dean, N. M., Kanemitsu, M. & Boynton, A. L. (1989) Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat tiver T51B cells. Biochem. Biophys. Res. Commun. 165: 795-801.
35. Watanabe, T., Kondo, K. & Oishi, M. (1991) Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases. Cancer Res. 51: 764-768.
36. Peterson, G. & Barnes, S. (1991) Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multidrug resistance gene. Biochem. Biophys. Res. Commun. 179: 661-667.
37. Markovits, J., Linassier, C., Fosse, P., Couprie, J., Pierre, J., Jacquemin-Sablon, A., Saucier, J.-M., Le Pecq, J.-B. & Larsen, A. K. (1989) Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 49: 5111-5117.
38. Constantinou, A., Kiguchi, K. & Huberman, E. (1990) Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 50: 2618-2624.
39. Kazuhiro, K., Tseuneizumi, K., Watanabe, T. & Oishi, M. (1991) Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases. Cancer Res. 51: 5398-5404.
40. Altruru, D., Jackson, T. M. & Altruru, S. (1991) Genistein, a selective protein tyrosine kinase inhibitor, inhibits interleukin-2 and leukotriene B4 production from human mononuclear cells. Clin. Immunol. Immuopathol. 59: 379-387.
41. Glaser, K. B., Sung, A., Bauer, J. & Weichman, B. M. (1993) Regulation of eicosanoid biosynthesis in the macrophage. Biochem. Pharmacol. 45: 711-721.
42. Yanagihara, K., Ito, A., Toge, T. & Numoto, M. (1993) Antiproliferative effect of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 53: 5815-5821.
43. Katagiri, K., Katagiri, T., Kajiyama, K., Uehara, Y., Yamaoto, T. & Yoshida, T. (1992) Modulation of monocytic differentiation H-60 cells by inhibitor of protein tyrosine kinase. Cell. Immunol. 140: 282-294.
44. Fotsis, T., Pepper, M., Adlercerutz, H., Fleischmann, G., Hase, T., Montesano, R. & Schweigerer, M. (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA 90: 2690-2694.
45. Uckun, F. M., Evans, W. E., Forsyth, C. J., Waddick, K. G., Ahlgren, L. T., Chelstrom, L. M., Burkhardt, A., Bolen, J. & Myers, D. E. (1995) Biotherapy of B-cell precursor leukemia by targeting genistein to CD 19-associated tyrosine kinases. Science 267: 886-891.
46. Kiguchi, K., Constantinou, A. & Huberman, E. (1990) Genistein-induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells. Cancer Commun. 2: 271-278.
47. Monon, L. G., Kuttan, R. & Nair, M. G. (1998) Effect of isoflavone genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. Nutr. Cancer 30: 74-77.
48. Li, D., Yee, J. A., McGuire, M. H. & Yan, F. (1999) Soybean isoflavones reduces experimental metastasis in mice. J. Nutr. 29: 1075-1078.
49. Wei, H., Bowen, R., Barnes, S., Cai, Q. & Wang, Y. (1995) Antioxidant and anticarcinogenic properties of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med. 208: 124-130.
50. Wei, H., Bowen, R., Zhang, X. & Lebwohl, M. (1998) Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis. Carcinogenesis 19: 1509-1514.
51. Wei, H., Wei, L., Frenkel, K., Bowen, R. & Barnes, S. (1993) Inhibition of tumor promoter-induced hydrogen peroxide production in vitro and in vivo by genistein. Nutr. Cancer 20: 1-12.
52. Cai, Q. & Wei, H. (1996) Effects of dietary genistein on antioxidant enzyme activities in Sencar mice. Nutr. Cancer 25: 1-7.
53. Wei, H., Barnes, S. & Wang, Y. (1995) The inhibition of tumor promoter-induced proto-oncogene expression mouse skin by soybean isoflavone genistein. Oncol. Rep. 3: 125-128.
54. Wang, Y., Yaping, E., Zhang, X., Lebwohl, M., Rosenstein, B. S., DeLeo, V. & Wei, H. (1998) Inhibition of ultraviolet B-induced c-fos and c-jun expression by genistein through a protein tyrosine kinase-dependent pathway. Carcinogenesis 19: 649-654.
55. Wei, H., Cai, Q. & Rhan, R. (1996) Inhibition of Fenton reaction and UV light-induced oxidative DNA damage by soybean isoflavone genistein. Carcinogenesis 17: 73-77.
56. Brown, A., Jolly, P. & Wei, H. (1998) Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apoptosis and regulation of tyrosine kinase activity and N-myc expression. Carcinogenesis 19: 991-997.
57. Miller, D. L. & Weinstock, M. A. (1994) Nonmelanoma skin cancer in the United States: incidence. J. Am. Acad. Dermatol. 30: 774-778.
58. Stern, R. S., Bolshakov, S., Nataraj, A. J. & Ananthaswamy, H. N. (2002) p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet A-treated patients: evidence for heterogeneity and field cancerization. J. Invest. Dermatol. 119: 522-526.
59. Shyong, E., Lu, Y., Lanzinsky, A., Saladi, R., Phelps, R. G., Austin, L., Lebwohl, M. & Wei, H. (2002) Effects of the isoflavone genistein on PUVA-induced photodamage. Carcinogenesis 23: 317-321.